Early research (Phase 1)Study completedNCT02154776
What this trial is testing
Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
Who this might be right for
Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 13